000 | 01874 a2200517 4500 | ||
---|---|---|---|
005 | 20250516171521.0 | ||
264 | 0 | _c20131122 | |
008 | 201311s 0 0 eng d | ||
022 | _a1473-5571 | ||
024 | 7 |
_a10.1097/QAD.0b013e32835fabc2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKalayjian, Robert C | |
245 | 0 | 0 |
_aOlder HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction. _h[electronic resource] |
260 |
_bAIDS (London, England) _cJun 2013 |
||
300 |
_a1563-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_aADP-ribosyl Cyclase 1 _xmetabolism |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAging _ximmunology |
650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHLA-DR Antigens _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor, Type II _xmetabolism |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aSpritzler, John | |
700 | 1 | _aMatining, Roy M | |
700 | 1 | _aFiscus, Susan A | |
700 | 1 | _aGross, Barry H | |
700 | 1 | _aFrancis, Isaac R | |
700 | 1 | _aPollard, Richard B | |
700 | 1 | _aLederman, Michael M | |
700 | 1 | _aLanday, Alan | |
773 | 0 |
_tAIDS (London, England) _gvol. 27 _gno. 10 _gp. 1563-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e32835fabc2 _zAvailable from publisher's website |
999 |
_c23099509 _d23099509 |